Astragaloside IV protects against podocyte injury via SERCA2- dependent ER stress reduction and AMPKα-regulated autophagy induction in streptozotocin-induced diabetic nephropathy
Home »
Publications » Astragaloside IV protects against podocyte injury via SERCA2- dependent ER stress reduction and AMPKα-regulated autophagy induction in streptozotocin-induced diabetic nephropathy
Publish Date 03/19/2025
Category
Keywords
Astragaloside IV protects against podocyte injury via SERCA2- dependent ER stress reduction and AMPKα-regulated autophagy induction in streptozotocin-induced diabetic nephropathy
Join the Arbor Assays Newsletter
Sign up for Arbor Assays’ email list to stay up to date on special deals, new kits, and published articles featuring Arbor Assays’ products
